Phase 2/Phase 3 Study To Evaluate The Efficacy And Safety Of Ramatroban Along With The Standard Of Care In Subjects Hospitalized For COVID Pneumonia
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Ajay Gupta, MD
KARE Biosciences
Principal Investigator - Deanna J Nelson, PhD
BioLink Life Sciences, Inc.
Study Director - Martin Ogletree, PhD
Points & Assists, LLC.
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Dec Health Care
Nellore, Andhra Pradesh, India
Recruiting - Shakti Superspecialty Hospital
Ahmedabad, Gujarat, India
Recruiting - Lifecare Hospital
Mumbai, Maharashtra, India
Recruiting - Pdea'S Ayurved Rugnalaya & Sterling Multispeciality Hospital
Pune, Maharashtra, India
Recruiting - Saikrupa Hospital
Pune, Maharashtra, India
Recruiting - Sangvi Multispecialty Hospital Pvt Ltd
Pune, Maharashtra, India
Recruiting - Spandan Hospital
Pune, Maharashtra, India
Recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 10 Nov 2022
- Primary completion
- 1 Jul 2024
- Completion
- 31 May 2026
- Last update posted
- 31 Jan 2023
- Registered enrollment
- 324
- Registry id
- NCT05706454
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.